Steve Pakola

Track

Insider profile

Steve Pakola's trades of Regenxbio Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Regenxbio Inc (RGNX)
Transaction date
Planned sale
Price
14.34
Quantity 42,724 +37.9%
Value US$4,095,542
US Regenxbio Inc (RGNX)
Transaction date
Planned sale
Price
242.72
Quantity 7,729 +32.7%
Value US$4,121,007
US Regenxbio Inc (RGNX)
Transaction date
Proposed sale
Price
283.55
Quantity 43,543
Value US$4,720,661
US Regenxbio Inc (RGNX)
Transaction date
Planned sale
Price
11.04
Quantity 19,608 -8.4%
Value US$216,472
US Regenxbio Inc (RGNX)
Transaction date
Planned sale
Price
11.02
Quantity 15,309 -6.2%
Value US$168,705
US Regenxbio Inc (RGNX)
Transaction date
Proposed sale
Price
10.55
Quantity 34,917
Value US$368,374
US Regenxbio Inc (RGNX)
Transaction date
Planned sale
Price
10.35
Quantity 5,124 -2.0%
Value US$53,033
US Regenxbio Inc (RGNX)
Transaction date
Proposed sale
Price
10.38
Quantity 5,124
Value US$53,187
US Regenxbio Inc (RGNX)
Transaction date
Planned sale
Price
28.36
Quantity 12,878 -10.7%
Value US$365,220
US Regenxbio Inc (RGNX)
Transaction date
Proposed sale
Price
21.36
Quantity 12,878
Value US$275,074
US Regenxbio Inc (RGNX)
Transaction date
Planned sale
Price
17.39
Quantity 17,237 -13.9%
Value US$299,789
US Regenxbio Inc (RGNX)
Transaction date
Proposed sale
Price
18.34
Quantity 17,237
Value US$316,127
US Regenxbio Inc (RGNX)
Transaction date
Planned sale
Price
22.17
Quantity 3,138 -20.5%
Value US$69,559
US Regenxbio Inc (RGNX)
Transaction date
Planned sale
Price
33.75
Quantity 1,598 -16.2%
Value US$53,932
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-06 2026-07-02
US Regenxbio Inc (RGNX)
PlS Planned sale
42,724 +37.9%
14.34
US$4,095,542 		42,724 +37.9% 14.34 US$4,095,542
2026-07-01 2026-07-01
US Regenxbio Inc (RGNX)
PlS Planned sale
7,729 +32.7%
242.72
US$4,121,007 		7,729 +32.7% 242.72 US$4,121,007
2026-07-01 2026-07-01
US Regenxbio Inc (RGNX)
PrS Proposed sale
43,543
283.55
US$4,720,661 		43,543 283.55 US$4,720,661
2026-07-01 2026-06-29
US Regenxbio Inc (RGNX)
PlS Planned sale
19,608 -8.4%
11.04
US$216,472 		19,608 -8.4% 11.04 US$216,472
2026-05-13 2026-05-11
US Regenxbio Inc (RGNX)
PlS Planned sale
15,309 -6.2%
11.02
US$168,705 		15,309 -6.2% 11.02 US$168,705
2026-05-11 2026-05-11
US Regenxbio Inc (RGNX)
PrS Proposed sale
34,917
10.55
US$368,374 		34,917 10.55 US$368,374
2026-03-12 2026-03-10
US Regenxbio Inc (RGNX)
PlS Planned sale
5,124 -2.0%
10.35
US$53,033 		5,124 -2.0% 10.35 US$53,033
2026-03-10 2026-03-10
US Regenxbio Inc (RGNX)
PrS Proposed sale
5,124
10.38
US$53,187 		5,124 10.38 US$53,187
2024-03-07 2024-03-05
US Regenxbio Inc (RGNX)
PlS Planned sale
12,878 -10.7%
28.36
US$365,220 		12,878 -10.7% 28.36 US$365,220
2024-03-05 2024-03-05
US Regenxbio Inc (RGNX)
PrS Proposed sale
12,878
21.36
US$275,074 		12,878 21.36 US$275,074
2024-01-04 2024-01-03
US Regenxbio Inc (RGNX)
PlS Planned sale
17,237 -13.9%
17.39
US$299,789 		17,237 -13.9% 17.39 US$299,789
2024-01-03 2024-01-03
US Regenxbio Inc (RGNX)
PrS Proposed sale
17,237
18.34
US$316,127 		17,237 18.34 US$316,127
2023-01-05 2023-01-03
US Regenxbio Inc (RGNX)
PlS Planned sale
3,138 -20.5%
22.17
US$69,559 		3,138 -20.5% 22.17 US$69,559
2022-01-04 2022-01-03
US Regenxbio Inc (RGNX)
PlS Planned sale
1,598 -16.2%
33.75
US$53,932 		1,598 -16.2% 33.75 US$53,932